Cargando…

SIRT6 Inhibitor, OSS_128167 Restricts Hepatitis B Virus Transcription and Replication Through Targeting Transcription Factor Peroxisome Proliferator-Activated Receptors α

Hepatitis B virus (HBV) is a major public health threat and anti-HBV drugs are limited to nucleos(t)ide analogs (NAs) and pegylated interferon alpha (Peg-IFNα). Toward identifying an effective compound for HBV treatment is important to suppress and eradicate HBV. In this study, we explored the anti-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Hui, Cheng, Sheng-Tao, Ren, Ji-Hua, Ren, Fang, Yu, Hai-Bo, Wang, Qing, Huang, Ai-Long, Chen, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823301/ https://www.ncbi.nlm.nih.gov/pubmed/31708789 http://dx.doi.org/10.3389/fphar.2019.01270

Ejemplares similares

SIRT6-specific inhibitor OSS-128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress
por: Huang, Yibo, et al.
Publicado: (2021)

Peroxisome proliferator-activated receptor alpha, PPARα, directly regulates transcription of cytochrome P450 CYP2C8
por: Thomas, Maria, et al.
Publicado: (2015)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022)

Salidroside Ameliorates Cardiomyocyte Hypertrophy by Upregulating Peroxisome Proliferator-Activated Receptor-α
por: Gao, Hui, et al.
Publicado: (2022)

The Role of Peroxisome Proliferator-Activated Receptors in Kidney Diseases
por: Gao, Jianjun, et al.
Publicado: (2022)

Analysis of the heat shock response in mouse liver reveals transcriptional dependence on the nuclear receptor peroxisome proliferator-activated receptor α (PPARα)
por: Vallanat, Beena, et al.
Publicado: (2010)

SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters
por: Wu, Dai-Qing, et al.
Publicado: (2022)

Peroxisome proliferator-activated receptors regulate the progression and treatment of gastrointestinal cancers
por: Zhang, Min, et al.
Publicado: (2023)

Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
por: Decara, Juan, et al.
Publicado: (2020)

Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations
por: Espinosa-Jiménez, Triana, et al.
Publicado: (2022)

Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases
por: Sharma, Vinesh, et al.
Publicado: (2022)

OSS reliability measurement and assessment
por: Yamada, Shigeru, et al.
Publicado: (2016)

Metabolomic Analysis Reveals the Therapeutic Effects of MBT1805, a Novel Pan-Peroxisome Proliferator-Activated Receptor Agonist, on α-Naphthylisothiocyanate-Induced Cholestasis in Mice
por: Wang, Chang, et al.
Publicado: (2021)

Fucoidan inhibits apoptosis and improves cardiac remodeling by inhibiting p53 transcriptional activation through USP22/Sirt 1
por: Wang, Shuai, et al.
Publicado: (2023)

The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy
por: Sun, Jiaao, et al.
Publicado: (2023)

Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
por: Göbel, Tamara, et al.
Publicado: (2019)

Peroxisome Proliferator-Activated Receptor-Gamma Reduces ER Stress and Inflammation via Targeting NGBR Expression
por: Ma, Jialing, et al.
Publicado: (2022)

Mega-oss and Mega-TCP versus Bio-Oss granules fixed by alginate gel for bone regeneration
por: Wang, Tong-Yue, et al.
Publicado: (2020)

Mechanistic insights into the peroxisome proliferator-activated receptor alpha as a transcriptional suppressor
por: Yagai, Tomoki, et al.
Publicado: (2022)

Peroxisome Proliferators Activated Receptor (PPAR) agonists activate hepatitis B virus replication in vivo
por: Du, Lingyao, et al.
Publicado: (2017)

Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats
por: Yang, Soo Jin, et al.
Publicado: (2011)

MOF Regulates TNK2 Transcription Expression to Promote Cell Proliferation in Thyroid Cancer
por: Li, Danyang, et al.
Publicado: (2020)

Fundamentals of EMS, NMS and OSS/BSS
por: Sathyan, Jithesh
Publicado: (2011)

Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
por: Fruchart, Jean-Charles
Publicado: (2013)

Expression of the Peroxisome Proliferator-Activated Receptors (PPARs) in the Hepatic Stellate Cells
por: Sato, Takeya, et al.
Publicado: (2004)

Comparative Evaluation of Gemcabene and Peroxisome Proliferator–Activated Receptor Ligands in Transcriptional Assays of Peroxisome Proliferator–Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease
por: Bisgaier, Charles L., et al.
Publicado: (2018)

Transcription Factors Involved in the Development and Prognosis of Cardiac Remodeling
por: Hong, Jia-Hui, et al.
Publicado: (2022)

AGK2, A SIRT2 Inhibitor, Inhibits Hepatitis B Virus Replication In Vitro And In Vivo
por: Yu, Hai-Bo, et al.
Publicado: (2018)

SIRT6 Depletion Sensitizes Human Hepatoma Cells to Chemotherapeutics by Downregulating MDR1 Expression
por: Xia, Yang Q., et al.
Publicado: (2018)

SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases
por: Manjula, Ramu, et al.
Publicado: (2021)

Dicer in action at replication-transcription collisions
por: Ren, Jie, et al.
Publicado: (2015)

Tonic Endocannabinoid Signaling Gates Synaptic Plasticity in Dorsal Raphe Nucleus Serotonin Neurons Through Peroxisome Proliferator-Activated Receptors
por: Oubraim, Saida, et al.
Publicado: (2021)

Regulation of Proteome Maintenance Gene Expression by Activators of Peroxisome Proliferator-Activated Receptor α
por: Ren, Hongzu, et al.
Publicado: (2010)

Bio-Oss(®) modified by calcitonin gene-related peptide promotes osteogenesis in vitro
por: Li, Yuanjing, et al.
Publicado: (2017)

SIRT6 Activator UBCS039 Inhibits Thioacetamide-Induced Hepatic Injury In Vitro and In Vivo
por: Jiao, Fangzhou, et al.
Publicado: (2022)

Framtiden hindrar oss att se Higgs
Publicado: (2009)

An evaluation and selection problems of OSS-LMS packages
por: Abdullateef, Belal Najeh, et al.
Publicado: (2016)

OSSE – open source registry software solution
por: Muscholl, Marita, et al.
Publicado: (2014)

Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
por: Lake, B G, et al.
Publicado: (1993)

Peroxisome Proliferator-Activated Receptor α Activation Induces Hepatic Steatosis, Suggesting an Adverse Effect
por: Yan, Fang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vp6cav7btuqn5h3l5kasjp6kmc